HealthLynked Corp Cash Flow Statement
HLYK|5 years of annual SEC 10-K data (FY2020-FY2024)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$3M
FY2024
Free Cash Flow
-$3M
FY2024
Capital Expenditures
$2,598
Cash used for long-term assets
Dividends Paid
N/A
FY2024
HealthLynked Corp used $3M in operating cash flow and negative free cash flow of $3M in FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -24.77 (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Net Income | -$6.1M | -$1.0M | -$8.8M | -$10.4M | -$5.8M |
| Depreciation & Amortization | $282.9K | $352.0K | $829.5K | $827.7K | $247.4K |
| Operating Cash Flow | -$3.5M | -$4.1M | -$4.4M | -$3.8M | -$2.1M |
| Capital Expenditures | $2.6K | $1.5K | $23.6K | $19.3K | $25.0K |
| Free Cash Flow | -$3.5M | -$4.1M | -$4.4M | -$3.8M | -$2.1M |
| Share Buybacks | - | - | - | $7.7K | - |
| FCF Margin | -116.2% | -72.5% | -74.9% | -58.3% | -34.9% |